Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial.
London NJS, Kaiser RS, Khan MA, Alshareef RA, Khuthaila M, Shahlaee A, Obeid A, London VA, DeCroos FC, Gupta OP, Hsu J, Vander JF, Spirn MJ, Regillo CD.
London NJS, et al. Among authors: khan ma.
Br J Ophthalmol. 2019 Sep;103(9):1306-1313. doi: 10.1136/bjophthalmol-2018-312839. Epub 2018 Oct 31.
Br J Ophthalmol. 2019.
PMID: 30381390